[go: up one dir, main page]

BR112015008366A2 - método de tratamento de câncer - Google Patents

método de tratamento de câncer

Info

Publication number
BR112015008366A2
BR112015008366A2 BR112015008366A BR112015008366A BR112015008366A2 BR 112015008366 A2 BR112015008366 A2 BR 112015008366A2 BR 112015008366 A BR112015008366 A BR 112015008366A BR 112015008366 A BR112015008366 A BR 112015008366A BR 112015008366 A2 BR112015008366 A2 BR 112015008366A2
Authority
BR
Brazil
Prior art keywords
treatment method
cancer treatment
cancer
treatment
Prior art date
Application number
BR112015008366A
Other languages
English (en)
Inventor
Klumper Edwin
Jan Platteeuw Johannes
De Bree Martijn
Original Assignee
Chamaeleo Pharma Bvba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chamaeleo Pharma Bvba filed Critical Chamaeleo Pharma Bvba
Publication of BR112015008366A2 publication Critical patent/BR112015008366A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR112015008366A 2012-10-15 2013-10-14 método de tratamento de câncer BR112015008366A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12188502 2012-10-15
PCT/EP2013/071438 WO2014060364A1 (en) 2012-10-15 2013-10-14 Sulfestrol for treating cancer

Publications (1)

Publication Number Publication Date
BR112015008366A2 true BR112015008366A2 (pt) 2017-07-04

Family

ID=47046412

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015008366A BR112015008366A2 (pt) 2012-10-15 2013-10-14 método de tratamento de câncer

Country Status (8)

Country Link
US (2) US20150283108A1 (pt)
EP (1) EP2906206A1 (pt)
JP (1) JP2016511218A (pt)
CN (1) CN105142622A (pt)
BR (1) BR112015008366A2 (pt)
CA (1) CA2888040A1 (pt)
MX (1) MX2015004761A (pt)
WO (1) WO2014060364A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE518690A (pt) 1952-04-07
WO2008045461A2 (en) 2006-10-11 2008-04-17 Oregon Health & Science University Transdermal diethylstilbestrol for treating prostate cancer
US8900634B2 (en) 2008-11-03 2014-12-02 Nal Pharmaceuticals, Ltd. Diethylstilbestrol dosage form and methods of treatment using thereof
JP5631327B2 (ja) * 2008-12-01 2014-11-26 シンタ ファーマシューティカルズ コーポレーション 増殖性障害を治療するための化合物
JP2014512337A (ja) * 2011-01-28 2014-05-22 ユニバーシティ オブ ケンタッキー リサーチ ファウンデーション スチルベン類似体およびがんを処置する方法

Also Published As

Publication number Publication date
CN105142622A (zh) 2015-12-09
EP2906206A1 (en) 2015-08-19
US20170246137A1 (en) 2017-08-31
US20150283108A1 (en) 2015-10-08
WO2014060364A1 (en) 2014-04-24
MX2015004761A (es) 2015-10-12
JP2016511218A (ja) 2016-04-14
CA2888040A1 (en) 2014-04-24

Similar Documents

Publication Publication Date Title
IL272206B (en) Combination therapy for treating cancer
IL267242B (en) Cancer treatment
BR112014007603A2 (pt) métodos de tratamento do câncer
BR112014032105A2 (pt) método para o tratamento de câncer
BR112014031806A2 (pt) método para tratamento de câncer positivo para gd2
DK2897620T3 (da) Fremgangsmåde til behandling af cancer
HUE046790T2 (hu) A rák kezelésének módszerei
HUE048780T2 (hu) Tauopátia kezelésére szolgáló módszerek
HUE046667T2 (hu) Rák kombinatív kezelése
CU24158B1 (es) Método de obtención de 1-kestosa
SG11201503893RA (en) Method of treating cancer
BR112014012880A2 (pt) tratamento imunogênico do câncer
HUE045314T2 (hu) Kombinációs terápia rák kezelésére
BR112015001100A2 (pt) método de detecção de câncer
BR112013011659A2 (pt) métodos de tratamento do câncer
BR112013022820A2 (pt) método de tratamento
EP2895206A4 (en) METHOD FOR TREATING CARCINOMA
BR112014011008A2 (pt) método de quantificação de tratamento de câncer
BR112013023142A2 (pt) método de tratamento de cabelos
EP2810066A4 (en) METHOD FOR THE TREATMENT OF CANCER
EP2789306A4 (en) TREATMENT SYSTEM
DK2872176T3 (en) Cancer treatment
HUE051592T2 (hu) Kezelési módszer
IL237150A0 (en) Treatment regimens
GB201222563D0 (en) Cancer treatment

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2483 DE 07-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.